TrialThe oncologist2025

Efficacy and safety of pyrotinib in patients with previously treated HER2-positive non-breast solid tumors: a phase 2, open-label basket trial.

Haojie Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.